Global AI in Healthcare Market

2.1    Scope of Study
2.2    Exclusion and Inclusion Criteria
2.3    Key Questions Answered in the Report

3.1    Primary Data Sources
3.2    Secondary Data Sources
3.3    Data Sources Categorization
3.4    Selection Criteria for Company Profiles
3.5    Brief Overview of the Market Estimation Process
3.6    Data Validation
3.7    Assumptions and Limitations

4.1    Industry Ecosystem
4.2    Funding Scenario
4.3    Readiness Index
4.4    Legal and Regulatory Framework
         4.4.1    Regulatory Framework in North America
                     4.4.1.1    U.S.
                                    4.4.1.1.1    Connected Devices
                                    4.4.1.1.2    Mobile Medical Apps (MMAs)
                                    4.4.1.1.3    Software-as-a-Medical-Device (SaMD)
                                                      4.4.1.1.3.1    General Considerations for SaMDs
         4.4.2    Regulatory Framework in Europe
         4.4.3    Regulatory Framework in Asia-Pacific
                     4.4.3.1    Regulatory Framework in China
4.5    Patent Analysis
         4.5.1    Insights About Awaited Technological Advancements
                     4.5.1.1    Age of AI-Integrated Robotics Surgery
                     4.5.1.2    Building an Integrated AI-Enabled Health Ecosystem
         4.5.2    Patent Filing Trend

5.1    Impact on Adoption of Artificial Intelligence in Healthcare
         5.1.1    Futuristic Impact of COVID-19 on AI Adoption in Healthcare
5.2    Key Developments During COVID-19 Pandemic
5.3    Impact on Market Size of Global AI in Healthcare Market
         5.3.1    Scenario Comparative Analysis
         5.3.2    Impact on Companies in Global AI in Healthcare
5.4    Regional Impact
         5.4.1    Impact of Vaccination on Regional AI Activities
5.5    Entry Barriers and Opportunities for Companies Entering Global AI in Healthcare Market

6.1    Market Share Analysis
         6.1.1    Market Share for Analysis for Medical Imaging and Diagnosis Autonomous Software Providers
         6.1.2    Competitive Benchmarking for Drug Discovery and Clinical Trials
6.2    Key Developments and Strategies
         6.2.1    Partnerships, Collaborations, and Agreements
         6.2.2    New Offerings
         6.2.3    Mergers and Acquisitions
         6.2.4    Funding Activities
         6.2.5    Regulatory and Legal Activities
6.3    Product Mapping Analysis
6.4    Business Model Analysis
6.5    Pipeline Analysis

7.1    Assumptions and Limitations
7.2    Key Findings and Opportunity Assessment
         7.2.1    Key Findings
         7.2.2    Opportunity Assessment
7.3    Market Dynamics
         7.3.1    Market Growth-Promoting Factors
                     7.3.1.1    Increasing Complexities of Clinical Decision-Making Leading to Higher Adoption of AI in Diagnostics
                     7.3.1.2    Progress in Healthcare IT Leading to an Expanding Array of Applications
                     7.3.1.3    Growing Need for Patient-Centric Care
                     7.3.1.4    Facilitation of Polypharmacology by AI
                     7.3.1.5    Growing Applications of AI in Health Informatics
                     7.3.1.6    Shortage of Healthcare Workforce to Drive Demand for Solutions Requiring Minimum or No Human Intervention
         7.3.2    Market Growth Inhibiting Factors
                     7.3.2.1    Lack of Clearly Defined Regulations
                     7.3.2.2    Data Security and Privacy Concerns
                     7.3.2.3    Barriers to Physician's Adoption of AI
                     7.3.2.4    Legal Implications of AI Systems
         7.3.3    Market Growth Opportunities
                     7.3.3.1    Capitalizing on Unmet Clinical Demand
                     7.3.3.2    Enabling Care at Home: Remote Monitoring
                     7.3.3.3    Leveraging Rapid Development in Deep Learning
                     7.3.3.4    Unlocking the Combined Potential of AI and Robotics
         7.3.4    Impact Analysis

8.1    Overview
8.2    AI-Integrated Hardware
8.3    Software and Services

9.1    Overview
9.2    Machine Learning
9.3    Deep Learning
9.4    Computer Vision
9.5    Natural Language Processing (NLP)
9.6    Others

10.1    Overview
10.2    Medical Imaging and Diagnosis
10.3    Virtual Assistance
10.4    Robot-Assisted Surgery
10.5    Drug Discovery and Clinical Trials
10.6    Data Management
10.7    Telemedicine
10.8    Remote Monitoring and Lifestyle Management
10.9    Others

11.1    Overview
11.2    Healthcare Providers
11.3    Pharmaceutical Companies
11.4    Academic Institutes and Research Centers
11.5    Healthcare Insurance Companies
11.6    Patients
11.7    Others

12.1    Overview
12.2    North America
           12.2.1    North America AI in Healthcare Market (by Product)
           12.2.2    North America AI in Healthcare Market (by End User)
           12.2.3    North America AI in Healthcare Market (by Country)
                         12.2.3.1    U.S.
                         12.2.3.2    Canada
12.3    Europe
           12.3.1    Europe AI in Healthcare Market (by Product)
           12.3.2    Europe AI in Healthcare Market (by End User)
           12.3.3    Europe AI in Healthcare Market (by Country)
                         12.3.3.1    Germany
                         12.3.3.2    France
                         12.3.3.3    U.K.
                         12.3.3.4    Italy
                         12.3.3.5    Spain
                         12.3.3.6    Rest-of-Europe
12.4    Asia-Pacific
           12.4.1    Asia-Pacific AI in Healthcare Market (by Product)
           12.4.2    Asia-Pacific AI in Healthcare Market (by End User)
           12.4.3    Asia-Pacific AI in Healthcare Market (by Country)
                         12.4.3.1    China
                         12.4.3.2    Japan
                         12.4.3.3    South Korea
                         12.4.3.4    Australia
                         12.4.3.5    India
                         12.4.3.6    Rest-of-Asia-Pacific
12.5    Rest-of-the-World
           12.5.1    Rest-of-the-World AI in Healthcare Market (by Product)
           12.5.2    Rest-of-the-World AI in Healthcare Market (by End User)
           12.5.3    Rest-of-the-World AI in Healthcare Market (by Country)
                         12.5.3.1    Brazil
                         12.5.3.2    Mexico
                         12.5.3.3    Argentina
                         12.5.3.4    Rest-of-Rest-of-the-World

13.1    Aidoc
13.2    Atomwise, Inc.
13.3    Babylon Health
13.4    Microsoft Corporation
13.5    Teladoc Health, Inc.

14.1    Activ Surgical Inc.
           14.1.1    Company Overview
           14.1.2    Role of Activ Surgical Inc. in the Global AI in Healthcare Market
           14.1.3    Recent Developments
           14.1.4    SWOT Analysis: Activ Surgical Inc.
14.2    Atomwise, Inc.
           14.2.1    Company Overview
           14.2.2    Role of Atomwise, Inc. in the Global AI in Healthcare Market
           14.2.3    Recent Developments
           14.2.4    SWOT Analysis: Atomwise, Inc.
14.3    Babylon Health
           14.3.1    Overview
           14.3.2    Role of Babylon Health in the Global AI in Healthcare Market
           14.3.3    Recent Developments
           14.3.4    SWOT Analysis: Babylon Health
14.4    BenevolentAI
           14.4.1    Company Overview
           14.4.2    Role of BenevolentAI in the Global AI in Healthcare Market
           14.4.3    Recent Developments
           14.4.4    SWOT Analysis: BenevolentAI
14.5    Butterfly Network, Inc.
           14.5.1    Company Overview
           14.5.2    Role of Butterfly Network, Inc. in the Global AI in Healthcare Market
           14.5.3    Recent Developments
           14.5.4    SWOT Analysis: Butterfly Network, Inc.
14.6    Freenome
           14.6.1    Company Overview
           14.6.2    Role of Freenome in the Global AI in Healthcare Market
           14.6.3    Recent Developments
           14.6.4    SWOT Analysis: Freenome
14.7    General Electric Company
           14.7.1    Company Overview
           14.7.2    Role of General Electric Company in the Global AI in Healthcare Market
           14.7.3    Recent Developments
           14.7.4    Financials
           14.7.5    SWOT Analysis: General Electric Company
14.8    International Business Machines Corporation (IBM)
           14.8.1    Company Overview
           14.8.2    Role of International Business Machines Corporation in the Global AI in Healthcare Market
           14.8.3    Recent Developments
           14.8.4    Financials
           14.8.5    SWOT Analysis: International Business Machines Corporation
14.9    Koninklijke Philips N.V.
           14.9.1    Company Overview
           14.9.2    Role of Koninklijke Philips N.V. in the Global AI in Healthcare Market
           14.9.3    Recent Developments
           14.9.4    Financials
           14.9.5    SWOT Analysis: Koninklijke Philips N.V.
14.10    Nuance Communications, Inc.
             14.10.1    Company Overview
             14.10.2    Role of Nuance Communications, Inc. in the Global AI in Healthcare Market
             14.10.3    Recent Developments
             14.10.4    Financials
             14.10.5    SWOT Analysis: Nuance Communications, Inc.
14.11    Nvidia Corporation
             14.11.1    Company Overview
             14.11.2    Role of Nvidia Corporation in the Global AI in Healthcare Market
             14.11.3    Recent Developments
             14.11.4    Financials
             14.11.5    SWOT Analysis: Nvidia Corporation
14.12    Olive
             14.12.1    Company Overview
             14.12.2    Role of Olive in the Global AI in Healthcare Market
             14.12.3    Recent Developments
             14.12.4    SWOT Analysis: Olive
14.13    Siemens Healthineers AG
             14.13.1    Company Overview
             14.13.2    Role of Siemens Healthineers AG in the Global AI in Healthcare Market
             14.13.3    Recent Developments
             14.13.4    Financials
             14.13.5    SWOT Analysis: Siemens Healthineers AG
14.14    Viz.ai, Inc.
             14.14.1    Company Overview
             14.14.2    Role of Viz.ai, Inc. in the Global AI in Healthcare Market
             14.14.3    Recent Developments
             14.14.4    SWOT Analysis: Viz.ai, Inc.
14.15    Zebra Medical Vision Ltd
             14.15.1    Company Overview
             14.15.2    Role of Zebra Medical Vision Ltd in the Global AI in Healthcare Market
             14.15.3    Recent Developments
             14.15.4    SWOT Analysis: Zebra Medical Vision Ltd

Table 4.1:    Global AI in Healthcare Market: Funding Scenario
Table 4.2:    IMDRF Classification: SaMD Categories
Table 4.3:    General Considerations for SaMDs
Table 4.4:    Challenges Faced in MDR Implementation
Table 4.5:    IMDRF Risk Classification: MDR
Table 4.6:    Regulatory Guidelines in China
Table 4.7:    Top Five CPCs for the Patents Filed During 2015-July 2020
Table 5.1:    Global AI in Healthcare Market, Impact on AI Adoption
Table 5.2:    Regional Impact of COVID-19
Table 6.1:    Global AI in Healthcare Market: Key Companies
Table 6.2:    Global AI in Healthcare Market, Competitive Benchmarking, Drug Discovery and Clinical Trials, 2019
Table 6.3:    Global AI in Healthcare Market: Company Product Mapping Analysis
Table 6.4:    Global AI in Healthcare Market: Business Models
Table 6.5:    Global AI in Healthcare Market: Key Product Pipeline
Table 7.1:    Factors Contributing to Diagnostic Errors in Primary Care
Table 11.1:    Global AI in Healthcare Market: Technology Utilization by Patients
Table 11.2:    Global AI in Healthcare Market: Technology Utilization by Patients
Table 12.1:    Impact Analysis of Drivers and Restraints of the North America AI in Healthcare Market
Table 12.2:    Impact Analysis of Drivers and Restraints of the Europe AI in Healthcare Market
Table 12.3:    Impact Analysis of Drivers and Restraints of the Asia-Pacific AI in Healthcare Market
Table 12.4:    Impact Analysis of Drivers and Restraints of the Rest-of-the-World AI in Healthcare Market

Figure 1:    Global AI in Healthcare Market, 2019-2030
Figure 2:    Key Applications of AI in Healthcare
Figure 3:    Impact Analysis of Drivers and Restraints of the Global AI in Healthcare Market
Figure 4:    Global AI in Healthcare Market, Funding Scenario, Q1-2018- Q3 2019
Figure 5:    Global AI in Healthcare Market: Patent Analysis (by Year), January 2015-July 2020
Figure 6:    Global AI in Healthcare Market, Share Analysis, 2019
Figure 7:    Global AI in Healthcare Market, Share of Key Developments and Strategies, January 2015- September 2020
Figure 8:    Global AI in Healthcare Market (by Application), 2019 Vs. 2030
Figure 9:    Global AI in Healthcare Market (by Technology), 2019 vs. 2030
Figure 10:    Global Emerging AI in Healthcare Market (by Region), 2019-2030
Figure 2.1:    Global AI in Healthcare Market Segmentation
Figure 2.2:    Regional AI in Healthcare Market Segmentation
Figure 3.1:    Global AI in Healthcare Market, Research Methodology
Figure 3.2:    Primary Research
Figure 3.3:    Secondary Research
Figure 3.4:    Total Number of Healthcare Company Profiles
Figure 3.5:    Assumptions and Limitations
Figure 4.1:    Global AI in Healthcare Market: Industry Structure
Figure 4.2:    Global AI in Healthcare Market (Technologies Readiness Index)
Figure 4.3:    AI/ML Workflow, TPLC Approach Proposed by FDA
Figure 4.4:    Building an Integrated AI-Enabled Health Ecosystem
Figure 4.5:    Global AI in Healthcare Market: Patent Analysis (by Country and Year), January 2015-July 2020
Figure 5.1:    Global AI in Healthcare Market: COVID-19 Impact on AI-Adoption
Figure 5.2:    Global AI in Healthcare Market: Key Developments During COVID-19 Pandemic
Figure 5.3:    Global AI in Healthcare Market: Growth Trend
Figure 5.4:    Global AI in Healthcare Market: Companies and Key Products During COVID-19
Figure 5.5:    Global AI in Healthcare Market: Entry Barriers and Opportunities for Companies
Figure 6.1:    Global AI in Healthcare Market, Share Analysis, 2019
Figure 6.2    Global AI in Healthcare Market Share Analysis for Medical Imaging and Diagnosis Autonomous Software Providers, 2019
Figure 6.3:    Global AI in Healthcare Market, Share of Key Developments and Strategies January 2015-September 2020
Figure 6.4:    Global AI in Healthcare Market, Key Developments (by Year) January 2015-September 2020
Figure 6.5:    Global AI in Healthcare Market – Key Partnerships, Collaborations, and Agreements, January 2015-September 2020
Figure 6.6:    Global AI in Healthcare Market, Key New Offerings, January 2015-September 2020
Figure 6.7:    Global AI in Healthcare Market – Key Mergers and Acquisitions, January 2015-September 2020
Figure 6.8:    Global AI in Healthcare Market – Key Funding Activities, January 2015-September 2020
Figure 6.9:    Global AI in Healthcare Market – Key Regulatory and Legal Activities, January 2015-September 2020
Figure 6.10:    Global AI in Healthcare Market Business Model Share Analysis, 2019
Figure 7.1:    Benefits of AI-Enabled Healthcare IT Solutions for Patients
Figure 7.2:    Some Applications of AI in Health Informatics
Figure 7.3:    Remote Monitoring Devices Enabling Care at Home
Figure 7.4:    AI and Robotics Combine to Benefit Several Areas in Healthcare
Figure 7.5:    Impact Analysis of Drivers and Restraints of the Global AI in Healthcare Market
Figure 8.1:    Global AI in Healthcare Market (by Product), $Million, 2019 and 2030
Figure 8.2:    Global AI in Healthcare Market (AI-Integrated Hardware), $Million, 2019-2030
Figure 8.3:    Global AI in Healthcare Market (Software and Services), $Million, 2019-2030
Figure 9.1:    Global AI in Healthcare Market (by Technology), $Million, 2019 and 2030
Figure 9.2:    Global AI in Healthcare Market (Machine Learning), $Million, 2019-2030
Figure 9.3:    Global AI in Healthcare Market (Deep Learning), $Million, 2019-2030
Figure 9.4:    Global AI in Healthcare Market (Computer Vision), $Million, 2019-2030
Figure 9.5:    Global AI in Healthcare Market (Natural Language Processing), $Million, 2019-2030
Figure 9.6:    Global AI in Healthcare Market (Other Technologies), $Million, 2019-2030
Figure 10.1:    Global AI in Healthcare Market (by Application), $Million, 2019 and 2030
Figure 10.2:    Global AI in Healthcare Market (Medical Imaging and Diagnosis), $Million, 2019-2030
Figure 10.3:    Global AI in Healthcare Market (Virtual Assistance), $Million, 2019-2030
Figure 10.4:    Global AI in Healthcare Market (Robot-Assisted Surgery), $Million, 2019-2030
Figure 10.5:    Global AI in Healthcare Market (Drug Discovery and Clinical Trials), $Million, 2019-2030
Figure 10.6:    Global AI in Healthcare Market (Data Management), $Million, 2019-2030
Figure 10.7:    Global AI in Healthcare Market (Telemedicine), $Million, 2019-2030
Figure 10.8:    Global AI in Healthcare Market (Remote Monitoring and Lifestyle Management, $Million, 2019-2030
Figure 10.9:    Global AI in Healthcare Market (Other Applications), $Million, 2019-2030
Figure 11.1:    Global AI in Healthcare Market (by End User), $Million, 2019 and 2030
Figure 11.2:    Global AI in Healthcare Market (Healthcare Providers) $Million, 2019-2030
Figure 11.3:    Global AI in Healthcare Market (Pharmaceutical Companies) $Million, 2019-2030
Figure 11.4:    Global AI in Healthcare Market (Academic Institutes and Research Centers) $Million, 2019-2030
Figure 11.5:    Global AI in Healthcare Market (Healthcare Insurance Companies) $Million, 2019-2030
Figure 11.6:    Global AI in Healthcare Market (Patients) $Million, 2019-2030
Figure 11.7:    Global AI in Healthcare Market (Other End Users) $Million, 2019-2030
Figure 12.1:    Global AI in Healthcare Market (by Region), 2019-2030
Figure 12.2:    Global AI in Healthcare Market (by Region), $Million, 2019-2030
Figure 12.3:    North America AI in Healthcare Market, $Million, 2019-2030
Figure 12.4:    North America AI in Healthcare Market (by Product), $Million, 2019-2030
Figure 12.5:    North America AI in Healthcare Market (by End User), $Million, 2019-2030
Figure 12.6:    North America AI in Healthcare Market, Share Analysis (by Country), 2019 and 2030
Figure 12.7:    U.S. AI in Healthcare Market, $Million, 2019-2030
Figure 12.8:    Canada AI in Healthcare Market, $Million, 2019-2030
Figure 12.9:    Europe AI in Healthcare Market, $Million, 2019-2030
Figure 12.10:    Europe AI in Healthcare Market (by Product), $Million, 2019-2030
Figure 12.11:    Europe AI in Healthcare Market (by End User), $Million, 2019-2030
Figure 12.12:    Europe AI in Healthcare Market Share Analysis (by Country), $Million, 2019 and 2030
Figure 12.13:    Germany AI in Healthcare Market, $Million, 2019-2030
Figure 12.14:    France AI in Healthcare Market, $Million, 2019-2030
Figure 12.15:    U.K. AI in Healthcare Market, $Million, 2019-2030
Figure 12.16:    Italy AI in Healthcare Market, $Million, 2019-2030
Figure 12.17:    Spain AI in Healthcare Market, $Million, 2019-2030
Figure 12.18:    Rest-of- Europe AI in Healthcare Market, $Million, 2019-2030
Figure 12.19:    Asia-Pacific AI in Healthcare Market, $Million, 2019-2030
Figure 12.20:    Asia-Pacific AI in Healthcare Market (by Product), $Million, 2019-2030
Figure 12.21:    Asia-Pacific AI in Healthcare Market (by End User), $Million, 2019-2030
Figure 12.22:    Asia-Pacific AI in Healthcare Market Share Analysis (by Country), 2019 and 2030
Figure 12.23:    China AI in Healthcare Market, $Million, 2019-2030
Figure 12.24:    Japan AI in Healthcare Market, $Million, 2019-2030
Figure 12.25:    South Korea AI in Healthcare Market, $Million, 2019-2030
Figure 12.26:    Australia AI in Healthcare Market, $Million, 2019-2030
Figure 12.27:    India AI in Healthcare Market, $Million, 2019-2030
Figure 12.28:    Rest-of-Asia-Pacific AI in Healthcare Market, $Million, 2019-2030
Figure 12.29:    Rest-of-the-World AI in Healthcare Market, $Million, 2019-2030
Figure 12.30:    Rest-of-the-World AI in Healthcare Market (by Product), $Million, 2019-2030
Figure 12.31:    Rest-of-the-World AI in Healthcare Market (by End User), $Million, 2019-2030
Figure 12.32:    Rest-of-the-World AI in Healthcare Market Share Analysis (by Country), 2019 and 2030
Figure 12.33:    Brazil AI in Healthcare Market, $Million, 2019-2030
Figure 12.34:    Mexico AI in Healthcare Market, $Million, 2019-2030
Figure 12.35:    Argentina AI in Healthcare Market, $Million, 2019-2030
Figure 12.36:    Rest-of-Rest-of-the-World AI in Healthcare Market, $Million, 2019-2030
Figure 14.1:    Activ Surgical Inc.: Product Offerings for the Global AI in Healthcare Market
Figure 14.2:    SWOT Analysis: Activ Surgical Inc.
Figure 14.3:    Atomwise, Inc.: Product Offerings for the Global AI in Healthcare Market
Figure 14.4:    SWOT Analysis: Atomwise, Inc.
Figure 14.5:    Babylon Health: Product Offerings for the Global AI in Healthcare Market
Figure 14.6:    SWOT Analysis: Babylon Health
Figure 14.7:    BenevolentAI: Product Offerings for the Global AI in Healthcare Market
Figure 14.8:    SWOT Analysis: BenevolentAI
Figure 14.9:    Butterfly Network, Inc.: Product Offerings for the Global AI in Healthcare Market
Figure 14.10:    SWOT Analysis: Butterfly Network, Inc.
Figure 14.11:    Freenome: Product Offerings for the Global AI in Healthcare Market
Figure 14.12:    SWOT Analysis: Freenome
Figure 14.13:    General Electric Company: Product Offerings for the Global AI in Healthcare Market
Figure 14.14:    General Electric Company: Overall Financials, 2017-2019
Figure 14.15:    General Electric Company: Revenue (by Segment), 2017-2019
Figure 14.16:    General Electric Company: Revenue (by Region), 2017-2019
Figure 14.17:    SWOT Analysis: General Electric Company
Figure 14.18:    International Business Machines Corporation: Product Offerings for the Global AI in Healthcare Market
Figure 14.19:    International Business Machines Corporation: Overall Financials, 2017-2019
Figure 14.20:    International Business Machines Corporation: Revenue (by Segment), 2017-2019
Figure 14.21:    International Business Machines Corporation (IBM): Revenue (by Region), 2017-2019
Figure 14.22:    SWOT Analysis: International Business Machines Corporation
Figure 14.23:    Koninklijke Philips N.V.: Product Offerings for the Global AI in Healthcare Market
Figure 14.24:    Koninklijke Philips N.V.: Overall Financials, 2017-2019
Figure 14.25:    Koninklijke Philips N.V.: Revenue (by Segment), 2017-2019
Figure 14.26:    Koninklijke Philips N.V.: Revenue (by Region), 2017-2019
Figure 14.27:    SWOT Analysis: Koninklijke Philips N.V.
Figure 14.28:    Nuance Communications, Inc.: Product Offerings for the Global AI in Healthcare Market
Figure 14.29:    Nuance Communications, Inc.: Overall Financials, 2017-2019
Figure 14.30:    Nuance Communications, Inc.: Revenue (by Segment), 2017-2019
Figure 14.31:    Nuance Communications, Inc.: Revenue (by Region), 2017-2019
Figure 14.32:    SWOT Analysis: Nuance Communications, Inc.
Figure 14.33:    Nvidia Corporation: Product Offerings for the Global AI in Healthcare Market
Figure 14.34:    NVIDIA Corporation: Overall Financials, 2017-2019
Figure 14.35:    NVIDIA Corporation: Revenue (by Segment), 2017-2019
Figure 14.36:    NVIDIA Corporation: Revenue (by Region), 2017-2019
Figure 14.37:    SWOT Analysis: Nvidia Corporation
Figure 14.38:    Olive: Product Offerings for the Global AI in Healthcare Market
Figure 14.39:    SWOT Analysis: Olive
Figure 14.40:    Siemens Healthineers AG: Product Offerings for the Global AI in Healthcare Market
Figure 14.41:    Siemens Healthineers AG: Overall Financials, 2017-2019
Figure 14.42:    Siemens Healthineers AG: Revenue (by Segment), 2017-2019
Figure 14.43:    Siemens Healthineers AG: Revenue (by Region), 2017-2019
Figure 14.44:    SWOT Analysis: Siemens Healthineers AG
Figure 14.45:    Viz.ai, Inc.: Product Offerings for the Global AI in Healthcare Market
Figure 14.46:    SWOT Analysis: Viz.ai, Inc.
Figure 14.47:    Zebra Medical Vision Ltd: Product Offerings for the Global AI in Healthcare Market
Figure 14.48:    SWOT Analysis: Zebra Medical Vision Ltd